Skip to main content
Top
Published in: Reactions Weekly 1/2015

01-04-2015 | Case report

Dabigatran etexilate

Subdural haemorrhage: case report

Published in: Reactions Weekly | Issue 1/2015

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literature
go back to reference Winkler AM, et al. Pathology consultation on monitoring direct thrombin inhibitors and overcoming their effects in bleeding patients. . American Journal of Clinical Pathology 140: 610-22, No. 5, Nov 2013 - USACrossRefPubMed Winkler AM, et al. Pathology consultation on monitoring direct thrombin inhibitors and overcoming their effects in bleeding patients. . American Journal of Clinical Pathology 140: 610-22, No. 5, Nov 2013 - USACrossRefPubMed
Metadata
Title
Dabigatran etexilate
Subdural haemorrhage: case report
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9176-1

Other articles of this Issue 1/2015

Reactions Weekly 1/2015 Go to the issue

Case report

Midazolam

Case report

Doxycycline

Case report

Zidovudine

Case report

Ziconotide